Option Care Health, Inc. (OPCH)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Option Care Health, Inc. (OPCH) trades at $27.27 with AI Score 43/100 (Weak). Option Care Health, Inc. is a leading provider of home and alternate site infusion services in the United States. Market cap: $4.33B, Sector: Healthcare.
Last analyzed: Feb 5, 2026Option Care Health, Inc. (OPCH) Healthcare & Pipeline Overview
Option Care Health delivers comprehensive infusion therapy services directly to patients' homes and alternate sites, offering a lower-cost, patient-centric alternative to traditional hospital settings, capitalizing on the growing demand for convenient and accessible healthcare with a P/E ratio of 26.69.
Investment Thesis
Option Care Health presents a notable research candidate due to its strong market position, diversified service offerings, and favorable industry trends. The company's focus on home and alternate site infusion services aligns with the growing demand for convenient and cost-effective healthcare solutions. With a gross margin of 19.4% and a profit margin of 3.8%, Option Care Health demonstrates its ability to generate sustainable profitability. Key value drivers include the increasing prevalence of chronic diseases, the shift towards value-based care, and the expansion of the company's service network. Upcoming catalysts include continued organic growth, strategic acquisitions, and the potential for new partnerships with healthcare providers and payers. Investors may want to evaluate Option Care Health for its long-term growth potential and its ability to deliver superior returns in the evolving healthcare landscape.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $5.55 billion, reflecting investor confidence in the company's growth prospects.
- P/E ratio of 26.69, indicating a reasonable valuation relative to earnings.
- Gross margin of 19.4%, demonstrating the company's ability to manage costs effectively.
- Profit margin of 3.8%, showcasing the company's profitability in a competitive market.
- Beta of 0.84, suggesting lower volatility compared to the overall market.
Competitors & Peers
Strengths
- Comprehensive range of infusion therapies and services.
- Established network of infusion centers and healthcare professionals.
- Strong relationships with healthcare providers and payers.
- Focus on patient-centered care and quality outcomes.
Weaknesses
- Dependence on reimbursement rates from payers.
- Exposure to regulatory changes and healthcare reforms.
- Competition from other home infusion providers.
- Potential for adverse events and liability claims.
Catalysts
- Ongoing: Continued organic growth driven by increasing demand for home infusion therapy.
- Ongoing: Strategic acquisitions to expand geographic reach and service capabilities.
- Upcoming: Potential for new partnerships with healthcare providers and payers.
- Ongoing: Technological innovation to improve operational efficiency and patient experience.
- Ongoing: Increased market penetration through expanded sales and marketing efforts.
Risks
- Potential: Changes in reimbursement policies that could reduce revenue.
- Ongoing: Increased competition from other home infusion providers.
- Potential: Adverse regulatory actions that could impact operations.
- Potential: Economic downturn and reduced healthcare spending.
- Ongoing: Dependence on key personnel and the ability to attract and retain talent.
Growth Opportunities
- Expansion of Service Offerings: Option Care Health can expand its service offerings to include additional therapies and services, such as specialty pharmacy services and remote patient monitoring. This would allow the company to cater to a broader range of patient needs and increase its revenue per patient. The market for specialty pharmacy services is estimated to be worth billions of dollars, providing a significant growth opportunity for Option Care Health. Timeline: Ongoing.
- Strategic Acquisitions: Option Care Health can pursue strategic acquisitions to expand its geographic reach and enhance its service capabilities. This would allow the company to enter new markets and gain access to new technologies and expertise. The market for home infusion services is fragmented, providing ample opportunities for consolidation. Timeline: Ongoing.
- Partnerships with Healthcare Providers and Payers: Option Care Health can forge partnerships with healthcare providers and payers to integrate its services into their care delivery models. This would allow the company to gain access to a larger patient population and improve its reimbursement rates. The shift towards value-based care is driving increased collaboration between healthcare providers and payers. Timeline: Ongoing.
- Technological Innovation: Option Care Health can invest in technological innovation to improve its operational efficiency and enhance the patient experience. This includes developing new software platforms, implementing remote patient monitoring systems, and leveraging data analytics to optimize care delivery. The market for healthcare technology is rapidly evolving, providing opportunities for Option Care Health to gain a competitive advantage. Timeline: Ongoing.
- Increased Market Penetration: Option Care Health can increase its market penetration by expanding its sales and marketing efforts and targeting new patient populations. This includes raising awareness of the benefits of home infusion therapy and educating healthcare providers about the company's services. The market for home infusion services is underpenetrated, providing ample opportunities for growth. Timeline: Ongoing.
Opportunities
- Expansion into new geographic markets.
- Development of new therapies and services.
- Strategic acquisitions and partnerships.
- Increased adoption of home infusion therapy.
Threats
- Changes in reimbursement policies.
- Increased competition from other providers.
- Adverse regulatory actions.
- Economic downturn and reduced healthcare spending.
Competitive Advantages
- Established network of infusion centers and healthcare professionals.
- Strong relationships with healthcare providers and payers.
- Comprehensive service offerings covering a wide range of therapies and conditions.
- Focus on providing high-quality, patient-centered care.
- Proprietary technology and data analytics capabilities.
About OPCH
Option Care Health, Inc. was founded to provide accessible and personalized infusion therapy services outside of traditional hospital settings. Recognizing the growing need for convenient and cost-effective healthcare solutions, the company has evolved into a leading provider of home and alternate site infusion services across the United States. Option Care Health offers a broad spectrum of therapies, including anti-infective treatments, home parenteral and enteral nutrition, immunoglobulin infusions, and treatments for chronic inflammatory and neurological disorders. These services cater to patients with a wide range of conditions, from cancer and heart failure to immune deficiencies and rare diseases. The company's commitment to patient care extends beyond therapy delivery, encompassing comprehensive nursing services and support to ensure optimal outcomes. Headquartered in Bannockburn, Illinois, Option Care Health operates a network of infusion centers and employs a team of skilled healthcare professionals dedicated to providing high-quality, patient-centered care. With a market capitalization of $5.55 billion, Option Care Health is strategically positioned to capitalize on the increasing demand for home-based healthcare solutions, offering a compelling value proposition for patients, providers, and payers alike. The company's focus on innovation and personalized care continues to drive its growth and solidify its position as a leader in the home infusion market.
What They Do
- Provides anti-infective therapies at home.
- Offers home infusion services for heart failure patients.
- Delivers parenteral and enteral nutrition support for various conditions.
- Administers immunoglobulin infusion therapies for immune deficiencies.
- Treats chronic inflammatory disorders like Crohn's disease and arthritis.
- Manages neurological disorders such as ALS and muscular dystrophy with infusion therapies.
- Provides infusion therapies for bleeding disorders.
- Offers specialized therapies for high-risk pregnancies.
Business Model
- Provides infusion therapies and related services in patients' homes and alternate sites.
- Contracts with healthcare providers and payers for reimbursement.
- Generates revenue through the delivery of therapies, nursing services, and other related services.
- Focuses on providing high-quality, patient-centered care to drive customer loyalty and referrals.
Industry Context
Option Care Health operates within the growing home infusion market, driven by the increasing prevalence of chronic diseases, the aging population, and the shift towards value-based care. The market is characterized by intense competition, with players ranging from large national providers to smaller regional operators. Option Care Health differentiates itself through its comprehensive service offerings, its focus on patient-centered care, and its established relationships with healthcare providers and payers. The company is well-positioned to capitalize on the increasing demand for home-based healthcare solutions, offering a compelling value proposition for patients, providers, and payers alike.
Key Customers
- Patients with acute and chronic conditions requiring infusion therapy.
- Hospitals and healthcare systems seeking to provide home-based infusion services.
- Physicians and other healthcare providers referring patients for infusion therapy.
- Managed care organizations and insurance companies covering the cost of infusion therapy.
Financials
Chart & Info
Option Care Health, Inc. (OPCH) stock price: $27.27 (+0.00, +0.00%)
Latest News
-
Earnings Scheduled For February 24, 2026
benzinga · Feb 24, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for OPCH.
Price Targets
Wall Street price target analysis for OPCH.
MoonshotScore
What does this score mean?
The MoonshotScore rates OPCH's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
OPCH Healthcare Stock FAQ
What does Option Care Health, Inc. do?
Option Care Health, Inc. is a leading provider of home and alternate site infusion services in the United States. They deliver a wide range of therapies, including anti-infectives, nutrition support, and treatments for chronic conditions like heart failure, immune deficiencies, and inflammatory disorders. Their business model revolves around providing these specialized infusion services directly to patients in the comfort of their homes or at convenient alternate sites, offering a cost-effective and patient-centric alternative to traditional hospital settings. This approach allows for personalized care and improved patient outcomes.
Is OPCH stock worth researching?
OPCH stock presents a mixed outlook. The company's strong market position and growing demand for home infusion services are positive indicators. However, the P/E ratio of 26.69 suggests a relatively high valuation. Investors may want to evaluate the company's growth potential, its ability to manage costs effectively (gross margin of 19.4%), and the potential risks associated with reimbursement rates and regulatory changes. A balanced analysis of these factors is crucial before making an investment decision. The company's beta of 0.84 suggests it is less volatile than the overall market.
What are the main risks for OPCH?
The main risks for OPCH include potential changes in reimbursement policies from payers, which could significantly impact revenue. Increased competition from other home infusion providers could also erode market share and profitability. Adverse regulatory actions and economic downturns leading to reduced healthcare spending pose additional threats. Furthermore, the company's dependence on key personnel and its ability to attract and retain talent are crucial for its continued success. Investors should carefully consider these risks before investing in OPCH.
What are the key factors to evaluate for OPCH?
Option Care Health, Inc. (OPCH) currently holds an AI score of 43/100, indicating low score. Key strength: Comprehensive range of infusion therapies and services.. Primary risk to monitor: Potential: Changes in reimbursement policies that could reduce revenue.. This is not financial advice.
How frequently does OPCH data refresh on this page?
OPCH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven OPCH's recent stock price performance?
Recent price movement in Option Care Health, Inc. (OPCH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Comprehensive range of infusion therapies and services.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider OPCH overvalued or undervalued right now?
Determining whether Option Care Health, Inc. (OPCH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying OPCH?
Before investing in Option Care Health, Inc. (OPCH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Stock data pending update.